2-(1H-benzimidazol-2-yl)-4-[2-(4-fluorophenyl)ethyl]-5-(1-pyrimidin-2-ylpiperidin-4-yl)-1H-pyrazol-3-one
C27H26FN7O — CID 146569118
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(1H-benzimidazol-2-yl)-4-[2-(4-fluorophenyl)ethyl]-5-(1-pyrimidin-2-ylpiperidin-4-yl)-1H-pyrazol-3-one
2-(1H-benzimidazol-2-yl)-4-[2-(4-fluorophenyl)ethyl]-5-(1-pyrimidin-2-ylpiperidin-4-yl)-1H-pyrazol-3-one (PubChem CID 146569118) has the molecular formula C27H26FN7O and a molecular weight of 483.55 g/mol. Its IUPAC name is 2-(1H-benzimidazol-2-yl)-4-[2-(4-fluorophenyl)ethyl]-5-(1-pyrimidin-2-ylpiperidin-4-yl)-1H-pyrazol-3-one.
Molecular Properties
| Compound Name | 2-(1H-benzimidazol-2-yl)-4-[2-(4-fluorophenyl)ethyl]-5-(1-pyrimidin-2-ylpiperidin-4-yl)-1H-pyrazol-3-one |
|---|---|
| PubChem CID | 146569118 |
| Molecular Formula | C27H26FN7O |
| Molecular Weight | 483.55 g/mol |
| Exact Mass | 483.22 |
| IUPAC Name | 2-(1H-benzimidazol-2-yl)-4-[2-(4-fluorophenyl)ethyl]-5-(1-pyrimidin-2-ylpiperidin-4-yl)-1H-pyrazol-3-one |
| SMILES | O=c1c(CCc2ccc(F)cc2)c(C2CCN(c3ncccn3)CC2)[nH]n1-c1nc2ccccc2[nH]1 |
| InChI | InChI=1S/C27H26FN7O/c28-20-9-6-18(7-10-20)8-11-21-24(19-12-16-34(17-13-19)26-29-14-3-15-30-26)33-35(25(21)36)27-31-22-4-1-2-5-23(22)32-27/h1-7,9-10,14-15,19,33H,8,11-13,16-17H2,(H,31,32) |
| InChIKey | ICRJIWVJXVYDIZ-UHFFFAOYSA-N |
| XLogP | 4.14 |
| TPSA | 95.49 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 483.55 |
| LogP ≤ 5 | 4.14 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146569118 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.